Hib-DTaP-hepatitis B-poliovirus vaccine - GlaxoSmithKline

Drug Profile

Hib-DTaP-hepatitis B-poliovirus vaccine - GlaxoSmithKline

Alternative Names: DTPa-HBV-IPV-Hib vaccine-GlaxoSmithKline; DTPa-HBV-IPV/Hib Vaccine-GlaxoSmithKline; DTPa-IPV/Hib; GSK 2036874A; GSK 21774; GSK217744; Haemophilus-influenzae-type-b-DTP-acellular-hepatitis-B-poliovirus-vaccine-GlaxoSmithKline; Hexavalent combination vaccine - GlaxoSmithKline; Hib-DTaP-hepatitis-B-poliovirus-vaccine-SmithKline-Beecham; Hib-DTP-acellular-hepatitis B-poliovirus vaccine - GlaxoSmithKline; Hib-DTP-acellular-hepatitis-B-poliovirus-vaccine-SmithKline-Beecham; Infanrix HepB-IPV/Hib; Infanrix HeXa; Infanrix®-IPV/Hib

Latest Information Update: 05 Jan 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GlaxoSmithKline
  • Class Haemophilus vaccines; Hepatitis B vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus

Most Recent Events

  • 25 Dec 2017 GlaxoSmithKline terminates a phase III trial prior to enrolment in Tetanus, Poliomyelitis, Pertussis, Hepatitis B, Haemophilus infections and Diphtheria (In infants) in India following reassessment of the medical need for the vaccine in the country (NCT03128489)
  • 02 May 2017 GlaxoSmithKline plans a phase III trial for Tetanus, Poliomyelitis, Pertussis, Hepatitis B, Haemophilus infections and Diphtheria (In infants) in India (IM) (NCT03128489)
  • 01 Sep 2016 Phase-III clinical trials in Tetanus, Poliomyelitis, Pertussis, Hepatitis B, Haemophilus infections and Diphtheria (Prevention, In infants) in Russia (IM) (NCT02858440)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top